Aileron Therapeutics enters into ATM equity distribution agreement for up to $50M with Citizens JMP

Rein Therapeutics, Inc.

New Equity Distribution Agreement with Citizens JMP Securities for at-the-market sales of common stock up to $50M.
Terminated prior Capital on Demand agreement with JonesTrading and William Blair effective July 26, 2024.
Agent commission set at 3.0% of gross proceeds from share sales.
Shares sold under existing shelf registration statement; no specific amount required to be sold.
Offering conducted on Nasdaq Capital Market; either party may suspend or terminate upon notice.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.